Clinical and epidemiological characterization in the follow-up of newborns with COVID-19: a descriptive study.

Introduction: COVID-19 disease affects newborns, but its middle and long-term effects are still unclear.

Objective: To describe the clinical and epidemiological characteristics and follow-up of newborns infected with SARS-CoV-2.

Methods: An observational and descriptive study.

Maternal-perinatal outcomes in pregnant women with covid-19 in a level III hospital in Peru.

The present study aimed to describe the perinatal outcomes of newborns of mothers with 2019 coronavirus infection identified before delivery in a level III hospital in Peru. Sociodemographic variables, obstetric complications, and neonatal morbidities were evaluated in the births that occurred between April 1 and June 30, 2020, at the National Maternal Perinatal Institute of Peru. 43 newborns were registered: 93% came from asymptomatic mothers, the most frequent obstetric complications were premature rupture of membranes (18.

[Perinatal outcomes and serological results in neonates of pregnant women seropositive to SARS-CoV-2: A cross-sectional descriptive study].

Introduction: SARS-CoV-2 has spread rapidly throughout the world. However, its ability to cause severe disease is not homogeneous according to sex and the different age groups.

Objective: To determine perinatal characteristics, morbidity, mortality, and serological results in neonates from seropositive pregnant women to SARS-CoV-2.

Transplantation in Congenital Heart Disease: A Challenge.

Background: Heart failure is the leading cause of death in grown-up congenital heart disease patients (GUCH). Although heart transplantation (OHT) remains the gold standard in end-stage heart failure, the ratio of GUCH patients undergoing this procedure remains low.

Objective: Describe the cohort of GUCH patients undergoing heart transplantation at a third-level hospital.

Short-term Use of Ventricular Assist Device in a Patient With Restrictive Cardiomyopathy: A Case Report.

The CentriMag (Levitronix LLC, Waltham, MA, USA) ventricular assist device is a centrifugal pump designed for short-term support in patients with cardiogenic shock. In patients with restrictive physiology, there is some concern about the use of these devices due a very small ventricular cavity. We review the evolution of a 32-year-old woman with restrictive cardiomyopathy, moderate pulmonary hypertension, and severe biventricular systo-diastolic dysfunction in whom a biventricular Centrimag device was implanted due to a progressive clinical worsening.